↓ Skip to main content

First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215…

Overview of attention for article published in Arthritis Research & Therapy, January 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
50 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215]
Published in
Arthritis Research & Therapy, January 2006
DOI 10.1186/ar1854
Pubmed ID
Authors

Ralf H Wittenberg, Ernest Schell, Gerhard Krehan, Roland Maeumbaed, Hans Runge, Peter Schlüter, Taiwo OA Fashola, Helen J Thurston, Klaus J Burger, Ulrich Trechsel

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Unknown 49 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 22%
Student > Master 9 18%
Other 8 16%
Student > Postgraduate 4 8%
Student > Doctoral Student 3 6%
Other 7 14%
Unknown 8 16%
Readers by discipline Count As %
Medicine and Dentistry 16 32%
Pharmacology, Toxicology and Pharmaceutical Science 5 10%
Nursing and Health Professions 3 6%
Psychology 3 6%
Neuroscience 3 6%
Other 12 24%
Unknown 8 16%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 July 2019.
All research outputs
#4,369,647
of 25,374,647 outputs
Outputs from Arthritis Research & Therapy
#967
of 3,381 outputs
Outputs of similar age
#18,056
of 173,461 outputs
Outputs of similar age from Arthritis Research & Therapy
#5
of 16 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,381 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 173,461 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.